omniture

China Medical Technologies to Present at the 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference

2008-01-22 16:02 1189


BEIJING, Jan. 22 /Xinhua-PRNewswire-FirstCall/ -- China Medical Technologies, Inc. (the "Company") (Nasdaq: CMED), a leading China-based medical device company that develops, manufactures and markets advanced in-vitro diagnostic products and high intensity focused ultrasound tumor therapy systems, today announces it will present at the 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference.

The Company's CEO, Mr. Xiaodong Wu, CFO, Mr. Sam Tsang and CTO, Dr. Zhong Chen will discuss their corporate strategies, operations and growth opportunities, as well as their published results to date with securities analysts and institutional investors.

Date: February 5-7, 2008

Location: New York

Presentation: February 5, 8:40am - 9:20am, Eastern Time

The webcast presentation will be available for 14 days following the live session on http://ir.chinameditech.com .

Please contact Merrill Lynch for more information about the conference.

About China Medical Technologies, Inc.

China Medical Technologies is a leading China-based medical device company that develops, manufactures and markets advanced in-vitro diagnostics products using Enhanced Chemiluminescence (ECLIA) technology and Fluorescent in situ Hybridization (FISH) technology, to detect and monitor various diseases and disorders, and products using High Intensity Focused Ultrasound (HIFU) for the treatment of solid cancers and benign tumors. For more information, please visit http://www.chinameditech.com .

For more information, please contact:

China Medical Technologies, Inc.

Winnie Fan

Tel: +86-10-6530-8833

Email: IR@chinameditech.com

Source: China Medical Technologies, Inc.
Related Stocks:
NASDAQ:CMED
collection